7BIO
CAS No. 916440-85-2
7BIO( —— )
Catalog No. M27496 CAS No. 916440-85-2
7-bromoindirubin-3'-oxime (7BIO) is a caspase independent nonapoptotic cell death inducer. 7BIO is an inhibitor of FLT3, DYRK1A, DYRK2, Aurora B and Aurora C kinases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 36 | Get Quote |
|
| 5MG | 58 | Get Quote |
|
| 10MG | 87 | Get Quote |
|
| 25MG | 177 | Get Quote |
|
| 50MG | 282 | Get Quote |
|
| 100MG | 447 | Get Quote |
|
| 500MG | 972 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name7BIO
-
NoteResearch use only, not for human use.
-
Brief Description7-bromoindirubin-3'-oxime (7BIO) is a caspase independent nonapoptotic cell death inducer. 7BIO is an inhibitor of FLT3, DYRK1A, DYRK2, Aurora B and Aurora C kinases.
-
Description7-bromoindirubin-3'-oxime (7BIO) is a caspase independent nonapoptotic cell death inducer. 7BIO is an inhibitor of FLT3, DYRK1A, DYRK2, Aurora B and Aurora C kinases.
-
In Vitro7BIO (1 and 10 μM; 24 hours) has neuroprotective effects and can prevent, but cannot rescue Aβ1?42 oligomer-induced cell death in SH-SY5Y cells. Cell Viability AssayCell Line:SH-SY5Y cellsConcentration:1 and 10 μMIncubation Time:24 hoursResult:Inhibit Aβ oligomer-induced neuronal death. 7BIO prevented, but did not rescue Aβ1?42 oligomer-induced cell death in SH-SY5Y cells.
-
In Vivo7Bio (2.3, 7.0, and 23.3 μg/kg; bilateral ventricle injection) significantly attenuates Aβ oligomer-induced impairment of recognition, spatial learning and memory in mice.7Bio (2.3, 7.0, and 23.3 μg/kg; bilateral ventricle injection) decreases Aβ oligomer-induced increase of TNF-α and IL-6 production in the brain and the expression of synapsin-1 and PSD-95 in the hippocampal region of mice.7Bio (2.3, 7.0, and 23.3 μg/kg; bilateral ventricle injection) attenuates Aβ oligomer-induced increase expression of pTau, activation of microglia and astrogliosis in the brain of mice.7Bio (2.3, 7.0, and 23.3 μg/kg; bilateral ventricle injection) prevents decreased expression of pSer9-GSK3β and has no significant effects on the Tau protein level. Animal Model:8 weeks mice (30 g)Dosage:2.3, 7.0, and 23.3 μg/kg Administration:bilateral ventricle injection Result:Attenuates Aβ oligomer-induced impairment of recognition, spatial learning and memory in mice.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetFLT
-
Recptorglutamine synthetase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number916440-85-2
-
Formula Weight356.179
-
Molecular FormulaC16H10BrN3O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (701.91 mM)
-
SMILESO\N=C1\C(\Nc2ccccc\12)=C1\C(=O)Nc2c1cccc2Br
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Premakumar R, Sorger GJ, Gooden D. Repression of nitrate reductase in Neurospora studied by using L-methionine-DL-sulfoximine and glutamine auxotroph gln-1b. J Bacteriol. 1980;143(1):411-415.
molnova catalog
related products
-
MRX-2843
MRX-2843 is a potent and orally active inhibitor of MERTK and FLT3(IC50s of 1.3 nM and 0.64 nM, respectively).
-
AKN-028
AKN-028 is an orally active and potent FLT3 tyrosine kinase inhibitor ( IC 50 = 6 nM). AKN-028 causes dose-dependent inhibition of FLT3 autophosphorylation.
-
Gilteritinib hemifum...
Gilteritinib hemifumarate (ASP2215 hemifumarate) is a potent ATP-competitive dual FLT3 (IC50: 0.29 nM) and AXL (IC50: 0.73 nM) inhibitor for the treatment of relapsed or refractory FLT3 mutant AML.
Cart
sales@molnova.com